NCT07158788Not yet recruiting
Role of Frailty in Bleeding Risk Prediction in Acute Coronary Syndrome
Incremental Value of Frailty Indices in Bleeding Risk Prediction Among Patients With Acute Coronary Syndrome
Source: ClinicalTrials.gov · Last updated 8 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Studying the incremental role of frailty in predicting in-hospital, short-term (30 days), and mid-term (6 months) bleeding in ACS patients.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 850 (estimated)
- First submitted
- 4 Sept 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Mar 2027
- Lead sponsor
- Assiut University
- Diseases
- Coronary artery disease
- NCT number
- NCT07158788
What you commit to
- Study type: Observational
- Planned participants: 850
- From 1 Oct 2025 to the primary completion date, 1 Mar 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- \- In - hospital death unrelated to bleeding
Age
- \- Patients younger than 65 years
Other
- \- Refusal of participation
Who the study is looking for
- \- Patients must be suffering from acute coronary syndrome ( STEMI - NSTEMI ) at the time of recruitment
- \- Patients must be older than 65 years
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.